InMed Pharmaceuticals Files 8-K Current Report
Ticker: INM · Form: 8-K · Filed: May 13, 2025 · CIK: 1728328
| Field | Detail |
|---|---|
| Company | Inmed Pharmaceuticals INC. (INM) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, current-report, sec-filing
TL;DR
InMed Pharma filed an 8-K, check for updates.
AI Summary
InMed Pharmaceuticals Inc. filed an 8-K on May 13, 2025, reporting an event on May 12, 2025. The filing indicates it is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The company is incorporated in British Columbia and its principal executive offices are located in Vancouver, Canada.
Why It Matters
This filing signifies a routine update or disclosure from InMed Pharmaceuticals Inc. to the SEC, which may contain important information for investors regarding company events.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for a current report, not indicating any immediate financial distress or significant negative events.
Key Players & Entities
- InMed Pharmaceuticals Inc. (company) — Filer of the 8-K report
- May 12, 2025 (date) — Earliest event date reported
- May 13, 2025 (date) — Date of report filing
- Vancouver, B.C. Canada (location) — Location of principal executive offices
FAQ
What specific event triggered this 8-K filing?
The filing states it is a 'Current Report' pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, but the specific event is not detailed in the provided text.
When was the earliest event reported?
The earliest event reported was on May 12, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at Suite 1445 - 885 W. Georgia Street, Vancouver, B.C. Canada, V6C 3E8.
What is the company's telephone number?
The company's telephone number, including area code, is (604) 669-7207.
In which jurisdiction is InMed Pharmaceuticals Inc. incorporated?
InMed Pharmaceuticals Inc. is incorporated in British Columbia.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding InMed Pharmaceuticals Inc. (INM).